Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Reassignment Surgery | 21 | 2023 | 39 | 11.550 |
Why?
|
| Transgender Persons | 17 | 2023 | 95 | 8.160 |
Why?
|
| Transsexualism | 13 | 2023 | 34 | 6.610 |
Why?
|
| Surgeons | 6 | 2024 | 238 | 2.550 |
Why?
|
| Face | 4 | 2023 | 114 | 1.880 |
Why?
|
| Penis | 4 | 2021 | 57 | 1.490 |
Why?
|
| Feminization | 2 | 2019 | 2 | 1.400 |
Why?
|
| Surgery, Plastic | 5 | 2023 | 42 | 1.270 |
Why?
|
| Gender Dysphoria | 3 | 2022 | 6 | 1.230 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 2903 | 1.070 |
Why?
|
| Cheek | 2 | 2023 | 22 | 0.920 |
Why?
|
| Patient Satisfaction | 5 | 2022 | 455 | 0.910 |
Why?
|
| Surgical Flaps | 3 | 2021 | 241 | 0.870 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 53 | 0.860 |
Why?
|
| Postoperative Complications | 4 | 2022 | 2207 | 0.850 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 113 | 0.830 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 196 | 0.790 |
Why?
|
| Humans | 51 | 2024 | 86644 | 0.780 |
Why?
|
| Hormones | 1 | 2021 | 141 | 0.760 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 153 | 0.740 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 66 | 0.740 |
Why?
|
| Mastectomy | 4 | 2023 | 243 | 0.730 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 394 | 0.730 |
Why?
|
| Insurance Coverage | 1 | 2021 | 117 | 0.720 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2018 | 11 | 0.650 |
Why?
|
| Female | 27 | 2023 | 44533 | 0.650 |
Why?
|
| Telemedicine | 1 | 2021 | 169 | 0.650 |
Why?
|
| Male | 23 | 2023 | 40966 | 0.620 |
Why?
|
| Sex Reassignment Procedures | 1 | 2017 | 4 | 0.610 |
Why?
|
| Nipples | 1 | 2015 | 37 | 0.510 |
Why?
|
| Education, Medical | 1 | 2017 | 233 | 0.480 |
Why?
|
| Quality of Life | 2 | 2023 | 1585 | 0.480 |
Why?
|
| Internship and Residency | 2 | 2023 | 1004 | 0.420 |
Why?
|
| Peer Review | 2 | 2022 | 24 | 0.410 |
Why?
|
| Gender Identity | 2 | 2023 | 52 | 0.410 |
Why?
|
| Genitalia | 2 | 2022 | 21 | 0.410 |
Why?
|
| Prostheses and Implants | 3 | 2023 | 121 | 0.390 |
Why?
|
| Phenylephrine | 1 | 2010 | 35 | 0.370 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 166 | 0.370 |
Why?
|
| Drug Labeling | 1 | 2010 | 41 | 0.360 |
Why?
|
| Medication Errors | 1 | 2010 | 39 | 0.360 |
Why?
|
| Emotions | 2 | 2023 | 341 | 0.360 |
Why?
|
| Vagina | 2 | 2021 | 161 | 0.360 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 53 | 0.360 |
Why?
|
| Rhinoplasty | 1 | 2010 | 34 | 0.360 |
Why?
|
| Patient-Centered Care | 2 | 2022 | 203 | 0.350 |
Why?
|
| Urethra | 2 | 2020 | 113 | 0.320 |
Why?
|
| Mucormycosis | 1 | 2008 | 14 | 0.320 |
Why?
|
| Maxillary Sinus | 1 | 2008 | 26 | 0.320 |
Why?
|
| Mental Health | 3 | 2023 | 162 | 0.310 |
Why?
|
| Skull | 2 | 2019 | 249 | 0.300 |
Why?
|
| Fibromatosis, Gingival | 1 | 2006 | 1 | 0.300 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2024 | 59 | 0.250 |
Why?
|
| United States | 7 | 2024 | 6672 | 0.240 |
Why?
|
| Facial Bones | 1 | 2023 | 37 | 0.230 |
Why?
|
| Vocal Cords | 1 | 2023 | 25 | 0.230 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 84 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3362 | 0.220 |
Why?
|
| Endoscopy | 2 | 2023 | 332 | 0.220 |
Why?
|
| Hyperplasia | 1 | 2022 | 148 | 0.220 |
Why?
|
| Voice | 1 | 2022 | 20 | 0.210 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 19 | 0.210 |
Why?
|
| Physician Incentive Plans | 1 | 2021 | 21 | 0.210 |
Why?
|
| Reimbursement, Incentive | 1 | 2021 | 37 | 0.200 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 30 | 0.200 |
Why?
|
| San Francisco | 1 | 2021 | 21 | 0.200 |
Why?
|
| Medicare | 2 | 2024 | 410 | 0.200 |
Why?
|
| Perioperative Period | 1 | 2021 | 25 | 0.200 |
Why?
|
| Peritoneum | 1 | 2021 | 57 | 0.200 |
Why?
|
| Infertility, Female | 1 | 2021 | 93 | 0.190 |
Why?
|
| Health Personnel | 1 | 2023 | 202 | 0.190 |
Why?
|
| Wound Healing | 1 | 2022 | 344 | 0.190 |
Why?
|
| Clitoris | 1 | 2020 | 4 | 0.190 |
Why?
|
| Estrogens | 1 | 2021 | 200 | 0.180 |
Why?
|
| Healthcare Disparities | 2 | 2023 | 371 | 0.180 |
Why?
|
| Skin Transplantation | 1 | 2021 | 172 | 0.180 |
Why?
|
| Infant, Newborn | 2 | 2023 | 2380 | 0.180 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 135 | 0.170 |
Why?
|
| Dermal Fillers | 1 | 2019 | 3 | 0.170 |
Why?
|
| Cephalometry | 1 | 2019 | 50 | 0.170 |
Why?
|
| Rhytidoplasty | 1 | 2019 | 11 | 0.170 |
Why?
|
| Penile Implantation | 1 | 2019 | 13 | 0.170 |
Why?
|
| Penile Prosthesis | 1 | 2019 | 23 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2009 | 74 | 0.170 |
Why?
|
| Aging | 2 | 2023 | 691 | 0.160 |
Why?
|
| Incidence | 2 | 2021 | 1577 | 0.160 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 567 | 0.160 |
Why?
|
| Social Media | 1 | 2019 | 79 | 0.160 |
Why?
|
| Medicaid | 1 | 2021 | 217 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2021 | 265 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2019 | 319 | 0.140 |
Why?
|
| Heart | 1 | 2019 | 539 | 0.140 |
Why?
|
| Contrast Media | 2 | 2015 | 1078 | 0.130 |
Why?
|
| Mammary Arteries | 1 | 2015 | 31 | 0.130 |
Why?
|
| Chin | 1 | 2014 | 8 | 0.130 |
Why?
|
| Wounds, Stab | 1 | 2014 | 9 | 0.130 |
Why?
|
| Young Adult | 2 | 2021 | 5976 | 0.130 |
Why?
|
| Graphite | 1 | 2014 | 12 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2020 | 8489 | 0.120 |
Why?
|
| Societies, Medical | 2 | 2021 | 572 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1036 | 0.120 |
Why?
|
| Foreign Bodies | 1 | 2014 | 63 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 2767 | 0.110 |
Why?
|
| Adult | 4 | 2021 | 25648 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2012 | 90 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 117 | 0.090 |
Why?
|
| Hematologic Diseases | 1 | 2009 | 79 | 0.090 |
Why?
|
| Patient Selection | 2 | 2009 | 685 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2021 | 7993 | 0.080 |
Why?
|
| Phosphatidylglycerols | 1 | 2008 | 5 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2008 | 34 | 0.080 |
Why?
|
| Middle Aged | 6 | 2015 | 25028 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 2008 | 48 | 0.080 |
Why?
|
| Evidence-Based Medicine | 3 | 2021 | 429 | 0.080 |
Why?
|
| Infliximab | 1 | 2008 | 151 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2008 | 224 | 0.080 |
Why?
|
| Antifungal Agents | 1 | 2008 | 117 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2008 | 207 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 166 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2012 | 2261 | 0.060 |
Why?
|
| Pedigree | 1 | 2006 | 966 | 0.060 |
Why?
|
| Aged | 4 | 2024 | 18415 | 0.060 |
Why?
|
| Thyroid Cartilage | 1 | 2023 | 1 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2003 | 38 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2023 | 80 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 80 | 0.050 |
Why?
|
| Portal Vein | 1 | 2002 | 120 | 0.050 |
Why?
|
| Hepatic Artery | 1 | 2002 | 83 | 0.050 |
Why?
|
| Strategic Planning | 1 | 2021 | 2 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 108 | 0.050 |
Why?
|
| Efficiency | 1 | 2021 | 40 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1376 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 335 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 268 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2021 | 175 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2021 | 146 | 0.050 |
Why?
|
| Forecasting | 1 | 2021 | 304 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2021 | 312 | 0.050 |
Why?
|
| Uterus | 1 | 2021 | 215 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 449 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 1999 | 17 | 0.040 |
Why?
|
| Thrombosis | 1 | 2002 | 296 | 0.040 |
Why?
|
| Penile Erection | 1 | 2019 | 22 | 0.040 |
Why?
|
| Safety | 2 | 2009 | 152 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 539 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1621 | 0.040 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 49 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 394 | 0.040 |
Why?
|
| Burns | 1 | 1999 | 131 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 469 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2023 | 751 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 1999 | 271 | 0.040 |
Why?
|
| Facial Injuries | 1 | 2014 | 19 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2002 | 1268 | 0.030 |
Why?
|
| Lacerations | 1 | 2014 | 28 | 0.030 |
Why?
|
| Skin | 1 | 2014 | 554 | 0.020 |
Why?
|
| Child | 2 | 2014 | 6927 | 0.020 |
Why?
|
| Intermittent Claudication | 1 | 1987 | 20 | 0.020 |
Why?
|
| Microspheres | 1 | 2003 | 101 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2003 | 72 | 0.010 |
Why?
|
| Albumins | 1 | 2003 | 133 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 197 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 197 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 685 | 0.010 |
Why?
|
| Tuberculosis, Hepatic | 1 | 1981 | 2 | 0.010 |
Why?
|
| Anthropometry | 1 | 1999 | 74 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1999 | 83 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 26582 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 3047 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 3612 | 0.010 |
Why?
|
| Neoplasms | 1 | 1987 | 2898 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 8981 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1987 | 20 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1987 | 710 | 0.000 |
Why?
|
| Angiography | 1 | 1981 | 208 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1987 | 1169 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1981 | 384 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1981 | 1565 | 0.000 |
Why?
|
| Liver | 1 | 1981 | 1230 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1981 | 736 | 0.000 |
Why?
|